article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

726/2004, 09 March 2021. 726/2004 , which essentially means duplicate MAAs for products authorized via the centralized procedure. EC Issues Notice on the Handling of Duplicate Marketing Authorization Applications (MAAs) of Pharmaceutical Products under Article 82(1) of Regulation (EC) No. Under Article 82(1) of Regulation (EC) No.

article thumbnail

Can Children Consent to the COVID Vaccine? The Case of Foster Care and Juvenile Justice

Bill of Health

2004) (“[T] the fundamental right to an opportunity for an education does not guarantee that a student cannot temporarily forfeit educational services through his own conduct. Comm’n of the States (March 2016), [link] (50 state survey on state constitutional rights to education). However, because Washington, D.C., 3d 868, 874 (Wyo.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Confident Learned Intermediaries Defeat Warning Causation

Drug & Device Law

2004) (no causation where prescriber “continues to prescribe [similar] medication. . . 8, 2019) (no causation where prescriber “testified that none of the additional risk information. . . 2004); In re Accutane Litigation , 2016 WL 355843, at *8-9 (N.J. 2004 WL 5628157, at *5 (W.D. See Ehlis v. Shire Richwood, Inc. ,

FDA 59
article thumbnail

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

2004) (another case we discussed in 2008 ), because the plaintiff failed to “produce[] evidence that the risk. . . Being “aware of what he considered a stronger warning,” the implanter nonetheless stated that the defendant’s product “was in his opinion the best option.” Warning causation likewise failed as a matter of law in Motus v.

Doctors 59
article thumbnail

Doctors Without Burdens:  Another Mesh Court Goes Backwards

Drug & Device Law

2004), where the Kentucky Supreme Court adopted the learned intermediary doctrine. Larkin did not discuss the standard for proximate causation or suggest, as Thacker implies, that informed consent is part of the inquiry. The first is Larkin v. Pfizer, Inc. , 3d 758, 769-70 (Ky.

Doctors 59
article thumbnail

Lovely Warnings Causation (and More) Mesh Decision from the Central District of California

Drug & Device Law

And the court agreed, finding that “the undisputed facts reflected that [the doctor] testified she read the IFU, relied on the warnings provided by [the defendant], believed she had a comprehensive informed consent process, and would have passed on a warning about the risk of severe and chronic pain to patients. Pfizer, Inc ,196 F.

Doctors 64